Clinical Trial Update: Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the combination of ezetimibe and fenofibrate in patients with mixed hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hypertriglyceridemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia, Hypertriglyceridemia | Phase 3 | Status: COMPLETED